From Csaba Horváth to Quality by Design: Visualizing Design Space in Selectivity Exploration of HPLC Separations - Pharmaceutical Business review

Pharmaceutical Business review is using cookies

Continue Learn More

More info about

July 17, 2012

From Csaba Horváth to Quality by Design: Visualizing Design Space in Selectivity Exploration of HPLC Separations

CASE STUDIES

A modern approach to HPLC method development within the Quality by Design framework: the multifactorial optimization of three critical HPLC method parameters.

To read this in full please click here

DOWNLOAD SPECIFICATIONS BROCHURE

Drug Discovery

Research & Development

SK pharmteco signs agreement to manufacture Ferring’s ADSTILADRIN

Telix Pharmaceuticals secures FDA fast track status for TLX101-CDx

Clinical Trials

Patient Enrollment

US FDA approves Avacta Group’s IND application for AVA6000

AM-Pharma enrols first patients in Covid-19 phase III trial

Regulation

Drug Filing

USFDA accepts NextPoint Therapeutics’s IND for NPX887

Mesoblast files applications with US FDA for HLHS therapy

Production & Sales

Manufacturing

Biocon signs licensing and supply deal for diabetes drug in Brazil

Merck to open new distribution centre in Brazil for Life Science sector

Packaging & Supply Chain

Packaging

Gerresheimer

PCI Pharma announces bottling line expansion at Rockford site

Suppliers

No data found

From Csaba Horváth to Quality by Design: Visualizing Design Space in Selectivity Exploration of HPLC Separations

Pharmaceutical Business review is using cookies

Research & Development

Patient Enrollment

Drug Filing

Manufacturing

Packaging

No data found

From Csaba Horváth to Quality by Design: Visualizing Design Space in Selectivity Exploration of HPLC Separations

From Csaba Horváth to Quality by Design: Visualizing Design Space in Selectivity Exploration of HPLC Separations

Top Products from